EUVIMEDObjevte EUVIMED
Open access · CC BY-NC-ND 4.0

An in vitro investigation of l ‐kynurenine, quinolinic acid, and kynurenic acid on B16 F10 melanoma cell cytotoxicity and morphology

Charlise Basson, June Cheptoo Serem, Yvette Nkondo Hlophe, Priyesh Bipath

Cell Biochemistry and Function · 2023-10 · 41 (7) · 912-922

DOI: 10.1002/cbf.3843 ↗

At a glance

Journal article in Cell Biochemistry and Function, published online on 2023-09-03. Written by Charlise Basson and 3 co-authors. Institution: Department of Physiology, School of Medicine, University of Pretoria, Pretoria, South Africa. Major MEDLINE topics: Quinolinic Acid, Kynurenic Acid, Melanoma, Experimental, Kynurenine. Cited 13 times so far (Crossref); 40 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Research Foundation, School of Medicine Research Committee, Research Development Program.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

The metastatic behavior of melanoma has accentuated the need for specific therapy targets. Compounds, namely l ‐kynurenine ( l ‐kyn), quinolinic acid (Quin), and kynurenic acid (KA) previously displayed antiproliferative and cytotoxic effects in vitro against cancer cells. Despite the growing interest in these compounds there are limited studies examining the in vitro effects on melanoma. In B16 F10 melanoma cells, RAW 264.7 macrophage cells, and HaCat keratinocyte cells, postexposure to the compounds, crystal violet staining was used to determine the half‐maximal inhibitory concentration (IC 50 ), whereas polarization‐optical transmitted light differential interference contrast and light microscopy after hematoxylin and eosin (H&E) staining was used to assess morphological changes. l ‐kyn, Quin, and KA‐induced cytotoxicity in all cell lines, with l ‐kyn being the most cytotoxic compound. l ‐kyn and KA at IC 50 ‐induced morphological changes in B16 F10, RAW 264.7, and HaCat cell lines, whereas Quin had effects on B16 F10 and RAW 264.7 cells but did not affect HaCat cells. l ‐kyn, Quin, and KA each display different levels of cytotoxicity, which were cell line specific. l ‐kyn was shown to be the most potent compound against all cell lines and may offer future treatment strategies when combined with other viable treatments against melanoma.

Subjects

MeSH terms (MEDLINE)

Quinolinic AcidKynurenic AcidMelanoma, ExperimentalKynurenineMiceAnimalsHumansRAW 264.7 CellsCell SurvivalCell Line, Tumor

Author keywords

kynurenic acidkynurenine metabolitesl-kynureninemelanomaquinolinic acid

Substances

Quinolinic AcidKynurenic AcidKynurenine

Authors and institutions

  • Department of Physiology, School of Medicine, University of Pretoria, Pretoria, South Africa.
  • Department of Anatomy, School of Medicine, University of Pretoria, Pretoria, South Africa.

Funding

  • National Research Foundation
  • School of Medicine Research Committee
  • Research Development Program
  • University of Pretoria

Cite

APA

Basson, C., Serem, J. C., Hlophe, Y. N., & Bipath, P. (2023). An in vitro investigation of l ‐kynurenine, quinolinic acid, and kynurenic acid on B16 F10 melanoma cell cytotoxicity and morphology. Cell Biochemistry and Function, 41(7), 912-922. https://doi.org/10.1002/cbf.3843

Vancouver

Basson C, Serem JC, Hlophe YN, Bipath P. An in vitro investigation of l ‐kynurenine, quinolinic acid, and kynurenic acid on B16 F10 melanoma cell cytotoxicity and morphology. Cell Biochemistry and Function. 2023;41(7):912-922. doi:10.1002/cbf.3843

BibTeX
@article{Basson2023,
  author = {Basson, Charlise and Serem, June Cheptoo and Hlophe, Yvette Nkondo and Bipath, Priyesh},
  title = {An in vitro investigation of l ‐kynurenine, quinolinic acid, and kynurenic acid on B16 F10 melanoma cell cytotoxicity and morphology},
  journal = {Cell Biochemistry and Function},
  year = {2023},
  volume = {41},
  number = {7},
  pages = {912--922},
  doi = {10.1002/cbf.3843}
}
Start for free →